Gene-editing techniques could soon allow researchers to replace entire genes and engineer complex cellular circuits — if the ...

A single intravenous infusion of an experimental CRISPR-Cas9 therapy cut LDL cholesterol by 52.5% in patients who received ...

NEW ORLEANS, LA—An investigational CRISPR-Cas9 gene-editing therapy that targets angiopoietin-like protein 3 (ANGPTL3), which has a role in regulating lipid metabolism, appears to safely lower levels ...

CRISPR-Cas9 has transformed the life sciences by giving researchers a seemingly simple tool for cutting DNA at chosen ...

The AI company Anthropic has announced that its Claude large language model has discovered a system reminiscent of CRISPR, ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

A tiny molecular scissor that once barely worked in human cells has been transformed into a high-performance genome-editing ...

Don't read too much into this year's lackluster performance. Near-term catalysts are firming up.

Gene editing companies traded lower on Wednesday after Anthropic (ANTHRO) announced that its AI model Claude has “autonomously discovered” a new enzyme system similar to the gene-editing tool CRISPR.

Experts at Tropic Biosciences, a UK company based in Norfolk, used a technique known as CRISPR-Cas9 to edit three genes that ...

A single dose of an experimental CRISPR therapy cut LDL cholesterol and triglycerides by about half in patients with difficult-to-treat lipid disorders. The reductions were still present one year ...